Data Insights
No Filter Selected
No Filter Selected
No Filter Selected
No Filter Selected
LUCARG-39D by Legend Biotech for B-Cell Non-Hodgkin Lymphoma: Likelihood of Approval
LUCARG-39D is under clinical development by Legend Biotech and currently in Phase I for B-Cell Non-Hodgkin Lymphoma. According to GlobalData,...
LUCARG-39D by Legend Biotech for Follicular Lymphoma: Likelihood of Approval
LUCARG-39D is under clinical development by Legend Biotech and currently in Phase I for Follicular Lymphoma. According to GlobalData, Phase...
LUCARG-39D by Legend Biotech for Diffuse Large B-Cell Lymphoma: Likelihood of Approval
LUCARG-39D is under clinical development by Legend Biotech and currently in Phase I for Diffuse Large B-Cell Lymphoma. According to...